BioXtreme
Stroke Rehabilitation Robotics
StartupBioXtreme is a Petah Tikva-based startup in the Health Tech & Life Sciences sector, established in 2010. Stroke Rehabilitation Robotics. The company has raised a total of $5.67M across 4 funding rounds, currently at the Seed stage. BioXtreme was founded by Nini Bluman and Haim Hoffman. Key investors include ExitValley, Office of the Chief Scientist, Gefen Biomed Investments, among 5 total investors. The company has 11-50 employees. Core technologies: Simulation & Imaging, Augmented Reality, Artificial Intelligence, Machinery & Robotics.
With $5.67M in total funding, BioXtreme is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageSeed
- ProductReleased
- ModelB2B
- Employees11-50
- HQPetah Tikva
- DistrictCenter District
- Last Round$166K
- ExitValleyLead
- Office of the Chief Scientist
- Gefen Biomed Investments
5 investors total
Nini BlumanCo-founder & CEO
Haim HoffmanCo-founder & CTO
3 articles covered by sources including www.jpost.com,
www.fitness-gaming.com,
www.israelbizreg.com.
What does BioXtreme do?
BioXtreme is developing robotics systems to assist in patient rehabilitation from strokes, traumatic brain injuries, and other neurological disorders. The compan'ys DeXtreme system integrates biofeedback and 3D virtual reality into real-life environments. The system uses precise measurements of muscle strength, range of motion, and other clinical scales to calculate and apply forces with high accuracy across the entire motion cycle. plaXtreme is an advanced robotic device designed to restore palm and finger motor skills in individuals who have experienced stroke, traumatic brain injuries, and other neurological conditions. Patient progress is recorded and saved on the easy-to-use learning system, which is user-friendly, mobile, and secured. The system is designed to reduce existing rehabilitation treatment times by 50%.
How much funding has BioXtreme raised?
BioXtreme has raised $5.67M in total funding across 4 rounds. The company is currently at the Seed stage. Key investors include ExitValley, Office of the Chief Scientist, Gefen Biomed Investments.
Who founded BioXtreme?
BioXtreme was founded in 2010 by Nini Bluman (Co-founder & CEO), Haim Hoffman (Co-founder & CTO).
What sector is BioXtreme in?
BioXtreme operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Simulation & Imaging, Augmented Reality, Artificial Intelligence, Machinery & Robotics. Target customers: Financial Services, Financial Products, Insurance, Healthcare & Life Sciences, Healthcare, Providers.
Where is BioXtreme located?
BioXtreme is based in Imber St 7, Petah Tikva, Israel, Center District.